Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms.

Saved in:
Bibliographic Details
Title: Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms.
Authors: Malherbe JA; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Fuller KA; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Arshad A; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Nangalia J; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK., Romeo G; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia., Hall SL; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia., Meehan KS; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Guo B; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Howman R; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia., Erber WN; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia.
Source: Journal of clinical pathology [J Clin Pathol] 2016 Feb; Vol. 69 (2), pp. 155-63. Date of Electronic Publication: 2015 Aug 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0376601 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-4146 (Electronic) Linking ISSN: 00219746 NLM ISO Abbreviation: J Clin Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26290261
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Malherbe+JA%22">Malherbe JA</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Fuller+KA%22">Fuller KA</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Arshad+A%22">Arshad A</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Nangalia+J%22">Nangalia J</searchLink>; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Romeo+G%22">Romeo G</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Hall+SL%22">Hall SL</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Meehan+KS%22">Meehan KS</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Guo+B%22">Guo B</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Howman+R%22">Howman R</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Erber+WN%22">Erber WN</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220376601%22">Journal of clinical pathology</searchLink> [J Clin Pathol] 2016 Feb; Vol. 69 (2), pp. 155-63. <i>Date of Electronic Publication: </i>2015 Aug 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Pub%2E+Group%22">BMJ Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0376601 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1472-4146 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219746%22">00219746 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Pathol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26290261
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jclinpath-2015-203177
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 155
    Titles:
      – TitleFull: Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Malherbe JA
      – PersonEntity:
          Name:
            NameFull: Fuller KA
      – PersonEntity:
          Name:
            NameFull: Arshad A
      – PersonEntity:
          Name:
            NameFull: Nangalia J
      – PersonEntity:
          Name:
            NameFull: Romeo G
      – PersonEntity:
          Name:
            NameFull: Hall SL
      – PersonEntity:
          Name:
            NameFull: Meehan KS
      – PersonEntity:
          Name:
            NameFull: Guo B
      – PersonEntity:
          Name:
            NameFull: Howman R
      – PersonEntity:
          Name:
            NameFull: Erber WN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2016 Feb
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1472-4146
          Numbering:
            – Type: volume
              Value: 69
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of clinical pathology
              Type: main
ResultId 1